However, a national Blue Health Intelligence study from the Blue Cross Blue Shield Association finds that more than 30% of patients dropped out of treatment after the first four weeks and 58% of patients taking the medications for weight loss discontinued use before seeing a clinical benefit
Cells 13(4):318 Al-Kufaishi AMA, Al-Musawi NJT (2024) Hypothalamus-pituitary-adrenal axis in patients with post-traumatic stress disorders and related to oxidative stress
Athletes must be aware of NCAA regulations concerning stimulants and understand the permissible limits to avoid inadvertent violations of anti-doping policies
Dietary antioxidant supplementation combined with quercetin improves cycling time trial performance
It appears to modulate neurotransmitter systems, including dopamine and serotonin, and has shown efficacy in counteracting damage induced by various neurotoxins, suggesting potential applications in neurological conditions like Parkinson's disease and schizophrenia-like models
doi: 10.1016/j.jsbmb.2015.04.007 43 LeeSKimJ-HKimMHongSParkHKimEJet al
